XBIOTECH INC. Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31)
XBIOTECH INC. (XBIT) had Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) of $0 as of 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:AssetsFairValueDisclosureRecurring · last filed 2018-03-16
- 2017-12-31: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $0.00.
- 2017-09-30: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $0.00.
- 2017-06-30: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $0.00.
- 2017-03-31: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $0.00.
| Period end | Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) | Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) as first filed |
|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-16 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-16 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 | $2.02K 10-K · filed 2016-03-30 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-13 | |
| 2014-12-31 | $0.00 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |